Please login to the form below

Not currently logged in
Email:
Password:

Beovu

This page shows the latest Beovu news and features for those working in and with pharma, biotech and healthcare.

Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD

Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD

Novartis has claimed an EMA approval for VEGF inhibitor Beovu, its new drug for a leading cause of blindness that is competing with Bayer’s big-selling Eylea product. ... The company is also trumpeting Beovu’s less frequent dosing schedule compared

Latest news

More from news
Approximately 2 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....